Literature DB >> 7839731

Activation of systemic and mucosal immune response following nasal administration of liposomes.

Y Aramaki1, Y Fujii, K Yachi, H Kikuchi, S Tsuchiya.   

Abstract

Adjuvant effects of liposomes on systemic and mucosal immune response were investigated following nasal administration to Balb/c mice. Bovine serum albumin (BSA)-specific serum IgG and salivary IgA levels were significantly elevated when BSA-associated liposomes were administered intranasally twice at 4-week intervals. Systemic immune response was activated only by negatively charged liposomes, while activation of mucosal immune response was independent of liposomal charge. Antigen localization in liposomes affected immune adjuvant effect; the mucosal immune response could be activated only by liposomes to whose surface BSA was attached, but the systemic immune response was activated by both liposomes to which antigens were attached and in which the encapsulating antigens occurred. The results suggest that the contribution of antigen-presenting cells in activation of systemic and mucosal immunity following intranasal administration is different.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7839731     DOI: 10.1016/0264-410x(94)90251-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.

Authors:  N K Childers; K L Miller; G Tong; J C Llarena; T Greenway; J T Ulrich; S M Michalek
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses.

Authors:  N K Childers; G Tong; S Mitchell; K Kirk; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 3.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 4.  Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system.

Authors:  H Y Wu; M W Russell
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice.

Authors:  D P Snider; B J Underdown; M R McDermott
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

Review 6.  Mucosal Vaccine Development Based on Liposome Technology.

Authors:  Valentina Bernasconi; Karin Norling; Marta Bally; Fredrik Höök; Nils Y Lycke
Journal:  J Immunol Res       Date:  2016-12-29       Impact factor: 4.818

Review 7.  Materials-based vaccines for infectious diseases.

Authors:  Yang Bo; Hua Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.